Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jan;75(1):23-32.
doi: 10.1007/s12020-021-02927-3. Epub 2021 Nov 13.

A contemporary clinical approach to genetic testing for heritable hyperparathyroidism syndromes

Sunita M C De Sousa  1   2   3 , Richard W Carroll  4 , Alex Henderson  5 , John Burgess  6   7 , Roderick J Clifton-Bligh  8   9
Affiliations
Review

A contemporary clinical approach to genetic testing for heritable hyperparathyroidism syndromes

Sunita M C De Sousa et al. Endocrine. 2022 Jan.

Abstract

Purpose: The improved access and affordability of next generation sequencing has facilitated the clinical use of gene panel testing to test concurrently patients for multiple heritable hyperparathyroidism syndromes. However, there is little guidance as to which patients should be selected for gene panel testing and which genes should be included in such panels. In this review, we provide a practical approach to considering, interpreting and managing genetic testing for familial primary hyperparathyroidism (PHPT) syndromes and familial hypocalciuric hypercalcaemia (FHH) in patients with PTH-dependent hypercalcaemia. We discuss known genes implicated in PHPT and FHH, testing criteria and yields, pre-test counselling, laboratory considerations, and post-test management.

Methods: In addition to reviewing the literature, we conducted audits of local genetic testing data to examine the real-world yield of genetic testing in patients with PTH-dependent hypercalcaemia.

Results: Our local audits revealed a positive genetic testing rate of 15-26% in patients with suspected hyperparathyroidism syndromes.

Conclusion: Based on the particular testing criteria met, affected patients should be tested for variants in the genes currently implicated in PHPT (MEN1, CDC73, RET, CDKN1B, GCM2, CASR) and/or FHH (CASR, GNA11, AP2S1). Patients should be provided with pre- and post-test counselling, including consideration of potential implications for family members.

Keywords: Familial hypocalciuric hypercalcaemia (FHH); Genetic testing; Hypercalcaemia; Hyperparathyroidism; Next generation sequencing (NGS).

PubMed Disclaimer

References

    1. S. Mariathasan, K.A. Andrews, E. Thompson, B.G. Challis, S. Wilcox, H. Pierce et al. Genetic testing for hereditary hyperparathyroidism and familial hypocalciuric hypercalcaemia in a large UK cohort. Clin. Endocrinol. (Oxf.) 93(4), 409–18 (2020)
    1. R.V. Thakker, Genetics of parathyroid tumours. J. Intern. Med. 280(6), 574–83 (2016) - PubMed
    1. R. Alrezk, F. Hannah-Shmouni, C.A. Stratakis, MEN4 and CDKN1B mutations: the latest of the MEN syndromes. Endocr. Relat. Cancer 24(10), T195–T208 (2017) - PubMed - PMC
    1. A. Frederiksen, M. Rossing, P. Hermann, C. Ejersted, R.V. Thakker, M. Frost, Clinical Features of Multiple Endocrine Neoplasia Type 4: Novel Pathogenic Variant and Review of Published Cases. J. Clin. Endocrinol. Metab. 104(9), 3637–46 (2019) - PubMed - PMC
    1. B. Guan, J.M. Welch, J.C. Sapp, H. Ling, Y. Li, J.J. Johnston et al. GCM2-Activating Mutations in Familial Isolated Hyperparathyroidism. Am. J. Hum. Genet 99(5), 1034–44 (2016) - PubMed - PMC

Substances

LinkOut - more resources